[Safety of the dipyramidole echocardiography test in elderly coronary disease patients].
We prospectively studied the feasibility and safety of high-dose dipyridamole echocardiography in 166 patients (77 younger and 89 elderly patients) referred for clinical evaluation of coronary artery disease. The feasibility of dipyridamole echocardiography test was 80.5% in the young and 82% in the elderly (p = n.s.). The incidence of side effects during dipyridamole echocardiography was similar in two groups, except for dyspnea which was observed in 20% in the older and 4% in the younger (p < 0.01). Our data demonstrate that the dypiridamole test combined with echocardiographic monitoring of regional myocardial contractility may be considered a valid non invasive method for evaluating coronary artery disease in the elderly.
D'Angelo
M
M
IRCCS Sanatrix, Pozzilli Isernia.
Simonelli
P
P
Del Mastro
L
L
Auriemma
F
F
Abate
R
R
Vetrano
A
A
D000367:Age Factors; D000368:Aged; D000789:Angina, Unstable; D003327:Coronary Disease / Q000000981:diagnostic imaging*; D004176:Dipyridamole / Q000008:administration & dosage / Q000009:adverse effects; D004305:Dose-Response Relationship, Drug; D004417:Dyspnea / Q000139:chemically induced; D004452:Echocardiography; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction; D011446:Prospective Studies
D004176:Dipyridamole
Sicurezza del test eco-dipiridamolo in pazienti coronaropatici anziani.